By combining these findings with those of studies indicating the tumor-promoting effects of increased RNF38 expression in clinical and animal models, we conclude that the level of RNF38 modulates cell responsiveness to TGF-β, thus playing an important role in HCC development. This evidence concerns the gene RNF38 and hepatocellular carcinoma.